NEJM Publishes ONDCP Op-Ed on Medical & Public Health Imperatives Surrounding Xylazine, Which Director Gupta Designated as an Emerging Drug Threat to Nation
April 27, 2023
April 27, 2023
WASHINGTON, April 27 (TNSjou) -- The White House Office of National Drug Control Policy issued the following news release:
* * *
"Xylazine poses a threat to public health... Our goal is for the designation of xylazine as an emerging threat and subsequent actions to begin to address this threat before it worsens and undermines efforts to reduce illicit fentanyl use in the United States."
* * *
The New England Journal of Medicine publis . . .
* * *
"Xylazine poses a threat to public health... Our goal is for the designation of xylazine as an emerging threat and subsequent actions to begin to address this threat before it worsens and undermines efforts to reduce illicit fentanyl use in the United States."
* * *
The New England Journal of Medicine publis . . .